Literature DB >> 9143241

Factors controlling T-cell migration across rat cerebral endothelium in vitro.

G Pryce1, D Male, I Campbell, J Greenwood.   

Abstract

The migration of lymphocytes through primary cultures of rat brain microvascular endothelial cell monolayers was examined in vitro by time-lapse videomicroscopy. Antigen-specific T cell line migration was dependent on the duration of culture (post-antigen stimulation) with exogenous interleukin-2 (IL-2). Peak migration (approximately 50% of T-cells during the 4 h migration assay) occurred after 4 days of culture with IL-2 but did not coincide with maximal expression of LFA-1, VLA-4 or the IL-2 receptor. On unstimulated endothelia antibody blockade of LFA-1 or ICAM-1 inhibited T-cell line migration to 8.0% and 6.8% of control values, respectively, whereas blocking VLA-4 and VCAM-1 had no effect. On IL-beta activated endothelium blocking LFA-1 and ICAM-1 was less effective (24.9% and 27.3% of control values, respectively) and blockade of VLA-4 and VCAM-1 brought about a reduction to 63.0% and 68.3% of controls respectively. Inhibition of IL-2-dependent proliferation with an IL-2 receptor blocking antibody also significantly inhibited T-cell migration to 22.2% of controls. Peripheral lymph node (PLN) lymphocytes could also be induced to migrate through untreated cerebral endothelial cell monolayers by cross-linking CD3 which was also time and IL-2-dependent with maximal migration (22.7%) occurring after three days in the presence of exogenous IL-2. Blocking LFA-or ICAM-1 resulted in a significant reduction in migration across IL-1 beta-activated endothelial cells to 17.4% and 20.9% of control values respectively although blocking the VLA-4/VCAM-1 interaction had no significant effect. Activation of PLN lymphocytes with concanavalin A for up to 5 days did not induce migration but when left in contact with the endothelial monolayer for 24 h migration reached 31.0%. These studies indicate that T-cells require a combination of signals to trigger the migratory phenotype which is necessary to enable them to penetrate the blood-brain barrier.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9143241     DOI: 10.1016/s0165-5728(97)00006-4

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  13 in total

1.  Monoclonal and Single Domain Antibodies Targeting β-Integrin Subunits Block Sexual Transmission of HIV-1 in In Vitro and In Vivo Model Systems.

Authors:  Janet Tai Guedon; Kun Luo; Hong Zhang; Richard B Markham
Journal:  J Acquir Immune Defic Syndr       Date:  2015-07-01       Impact factor: 3.731

2.  Interactions between brain endothelial cells and human T-cell leukemia virus type 1-infected lymphocytes: mechanisms of viral entry into the central nervous system.

Authors:  I A Romero; M C Prevost; E Perret; P Adamson; J Greenwood; P O Couraud; S Ozden
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

3.  Proinflammatory cytokine gene induction by human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 Tax in primary human glial cells.

Authors:  Prabal Banerjee; Rosemary Rochford; J Antel; G Canute; Stephen Wrzesinski; Michelle Sieburg; Gerold Feuer
Journal:  J Virol       Date:  2006-11-22       Impact factor: 5.103

4.  A cytokine-controlled mechanism for integrated regulation of T-lymphocyte motility, adhesion and activation.

Authors:  Sten-Erik Bergström; Eva Bergdahl; Karl-Gösta Sundqvist
Journal:  Immunology       Date:  2013-12       Impact factor: 7.397

5.  Suppression of autoimmune retinal disease by lovastatin does not require Th2 cytokine induction.

Authors:  Rachel Harry; Matthew Gegg; Deborah Hankey; Hadi Zambarakji; Gareth Pryce; David Baker; Virginia Calder; Peter Adamson; John Greenwood
Journal:  J Immunol       Date:  2005-02-15       Impact factor: 5.422

6.  Inhibition of Rho GTPases with protein prenyltransferase inhibitors prevents leukocyte recruitment to the central nervous system and attenuates clinical signs of disease in an animal model of multiple sclerosis.

Authors:  John Greenwood; Peter Adamson; Claire E Walters; Gareth Pryce; Deborah J R Hankey; Said M Sebti; Andrew D Hamilton; David Baker
Journal:  J Immunol       Date:  2002-04-15       Impact factor: 5.422

7.  Lovastatin inhibits brain endothelial cell Rho-mediated lymphocyte migration and attenuates experimental autoimmune encephalomyelitis.

Authors:  John Greenwood; David Baker; Peter Adamson; Claire E Walters; Gareth Pryce; Naheed Kanuga; Evelyne Beraud
Journal:  FASEB J       Date:  2003-03-05       Impact factor: 5.191

Review 8.  Pharmacological targeting of ICAM-1 signaling in brain endothelial cells: potential for treating neuroinflammation.

Authors:  Patric Turowski; Peter Adamson; John Greenwood
Journal:  Cell Mol Neurobiol       Date:  2005-02       Impact factor: 5.046

Review 9.  Role of immunity in recovery from a peripheral nerve injury.

Authors:  Virginia M Sanders; Kathryn J Jones
Journal:  J Neuroimmune Pharmacol       Date:  2006-03       Impact factor: 7.285

10.  Intracellular domain of brain endothelial intercellular adhesion molecule-1 is essential for T lymphocyte-mediated signaling and migration.

Authors:  John Greenwood; Claire L Amos; Claire E Walters; Pierre-Olivier Couraud; Ruth Lyck; Britta Engelhardt; Peter Adamson
Journal:  J Immunol       Date:  2003-08-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.